We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Beneath a Covid Vaccine Debacle, 30 Years of Government Culpability
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Politics > Beneath a Covid Vaccine Debacle, 30 Years of Government Culpability
Beneath a Covid Vaccine Debacle, 30 Years of Government Culpability
Politics

Beneath a Covid Vaccine Debacle, 30 Years of Government Culpability

Last updated: December 23, 2021 10:00 am
Editorial Board Published December 23, 2021
Share
SHARE
00emergent vaccinehub top facebookJumbo

At first, it appeared that the agency had attracted two large pharmaceutical firms — Novartis and GlaxoSmithKline — but their involvement proved temporary. The companies already had contracts with the agency to work on vaccines for influenza pandemics. It was a distinct corner of biodefense that attracted major manufacturers because they could use much of the same technology and equipment for their seasonal flu shots.

In 2012, BARDA incorporated Novartis’s flu vaccine plant in North Carolina into the new program, and GlaxoSmithKline agreed to work as a subcontractor to another winning bidder, Texas A&M University.

Within a few years, however, both pharmaceutical firms bowed out. Novartis decided to get out of the flu vaccine business, and GlaxoSmithKline stopped participating in the program with Texas A&M. The university soldiered on, and in 2020, the government enlisted it to manufacture Novavax’s Covid-19 vaccine, which is not yet authorized for use in the United States.

But it was the third winning bidder that the government relied on most heavily when the coronavirus pandemic arrived: Emergent.

‘Eyes Wide Open’

At a congressional hearing this May, the scene was eerily familiar, but this time the crisis was unparalleled in scale.

Mr. El-Hibri, facing irate questioning, declared Emergent’s manufacturing troubles “unacceptable” and pledged improvements — much as he had two decades earlier when called to answer for his company’s struggles making anthrax vaccines. Emergent was hardly flawless, he said, but it had taken on a difficult task when others had not.

“Everyone went into this with their eyes wide open,” Mr. El-Hibri testified, “that this is a facility that had never manufactured a licensed product before, that it’s a facility that, although not in perfect condition, far from it, was the facility that had the highest level of state of readiness.”

You Might Also Like

NYC Mayor Adams stories greatest fundraising haul since indictment

Republican Senate rolls again SALT cap to $10K in Trump price range invoice

NYC Mayor Adams addresses backlash over smoking cigars with antisemitic influencer Sneako

Trump: Immigration crackdown to give attention to NYC, different ‘crime-ridden inner cities’

Early voting in NYC’s 2025 elections greater than doubles 2021 turnout

TAGGED:AnthraxAstraZeneca PLCBiden, Joseph R JrBiological and Chemical WarfareBiomedical Advanced Research and Development AuthorityBotulismCoronavirus (2019-nCoV)Defense DepartmentDrugs (Pharmaceuticals)El-Hibri, FuadEmergent BioSolutions IncEpidemicsFood and Drug AdministrationGaithersburg (Md)Government Contracts and ProcurementJohnson&JohnsonModerna IncPolitics and GovernmentPublic-Private Sector CooperationSmallpoxStockpilingThe Washington MailUnited StatesVaccination and Immunization
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
What to Do When Airlines Cancel Travel Vouchers
Lifestyle

What to Do When Airlines Cancel Travel Vouchers

Editorial Board April 29, 2022
England’s diabetes prevention program as a blueprint for Canada
GGP publicizes Collegiate Video games Competitors with $90K in prizes
Zencoder launches Zen Brokers, ushering in a brand new period of team-based AI for software program improvement
With ‘The Saints,’ Martin Scorsese places his religion in Fox Nation

You Might Also Like

FAA nominee reportedly lacks business pilot certification he claimed to have
Politics

FAA nominee reportedly lacks business pilot certification he claimed to have

June 16, 2025
LEONARD GREENE: ‘No Kings’ protesters rain on Trump’s navy parade
Politics

LEONARD GREENE: ‘No Kings’ protesters rain on Trump’s navy parade

June 15, 2025
The Military is ready to rejoice 250 years with a parade that coincides with Trump’s birthday
Politics

The Military is ready to rejoice 250 years with a parade that coincides with Trump’s birthday

June 14, 2025
Marines are seen standing guard at a federal constructing in Los Angeles
Politics

Marines are seen standing guard at a federal constructing in Los Angeles

June 13, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?